Hackberry Pollen Allergy: The Hemp-Family Urban Tree and Early Spring Symptoms
Hackberry pollen allergy is caused by windborne pollen from Celtis occidentalis and C. laevigata — urban shade trees in the Cannabaceae family, the same family as Cannabis sativa (hemp) and Humulus (hop). Pollen season runs late February through April, making hackberry one of the earliest spring urban tree pollens. No allergens have been characterized, but family membership with hemp raises a cross-reactivity hypothesis worth knowing. Most spring symptoms attributed to hackberry are likely multi-allergen urban tree pollen exposures.
Free · 5 min · Insurance accepted
Key facts
Hackberry (Celtis) belongs to Cannabaceae — the same family as Cannabis sativa and Humulus (hop) — creating a 3-species cross-reactivity hypothesis that remains clinically unconfirmed in any published study
Hackberry pollen season runs late February through April — 1 of the earliest spring urban tree pollen sources in the midwestern and southern US, often preceding oak and birch by 3–4 weeks
0 WHO/IUIS allergens have been characterized for any Celtis species despite hackberry being a dominant urban shade tree planted across the US Great Plains and mid-South.
Hackberry pollen season overlaps with elm (Ulmus, February to April) — both wind-pollinated urban trees contribute to early spring symptoms 4–6 weeks before patients expect allergy season to begin
Urban trees like hackberry are planted along roads and in parks, creating localized high-exposure pollen environments with concentrations up to 5× higher than rural background levels during the late February to April window
What Is Hackberry Pollen Allergy?
Hackberry pollen allergy is a suspected IgE-mediated respiratory allergy to windborne pollen from Celtis occidentalis (common hackberry) and C.
laevigata (sugarberry) — deciduous shade trees now classified in the Cannabaceae family, the same plant family as Cannabis sativa (hemp/marijuana) and Humulus (hop vines). Hackberry is wind-pollinated with a pollen season beginning in late February — making it one of the earliest urban tree pollens to release each spring — and continuing through April. Despite widespread planting throughout eastern and central US urban landscapes, hackberry has no WHO/IUIS-characterized pollen allergens and limited published clinical data on sensitization rates or reaction mechanisms.
Some skin prick test positivity has been documented in urban populations, and published French case data (Ickovic et al., 1993) identified Celtis australis as a new allergenic pollen, establishing that the genus produces allergens capable of sensitizing atopic individuals. The most clinically distinctive feature of hackberry allergy is its Cannabaceae family context: the same family as hemp (Cannabis sativa), Japanese hop (Humulus japonicus), and common hop (Humulus lupulus).
Whether hackberry pollen allergens cross-react with Cannabis allergens (Can s 2/3/4/5) or Humulus allergens (Hum j 6) is an unanswered research question. Hackberry was formerly classified in Ulmaceae (elm family) — a phylogenetically close relation that adds additional cross-reactivity context, as elm pollen is a documented aeroallergen.
Symptoms of Hackberry Pollen Allergy
Recognizing symptoms early helps you get the right treatment faster.
Early spring rhinitis
mildNasal congestion, sneezing, and rhinorrhea beginning in late February when hackberry is one of the few urban trees actively pollinating.
Allergic conjunctivitis
mildItchy, watery eyes during late February through April hackberry pollen season; often concurrent with other early spring tree pollens.
Sneezing
mildEpisodic sneezing associated with outdoor activity in urban areas with hackberry street trees during pollen release.
Pharyngeal pruritus
mildPosterior throat and palatal itch from windborne pollen deposition on oropharyngeal mucosa during the pollen season.
Spring asthma exacerbation
moderateUrban tree pollen from multiple species including hackberry can contribute to spring asthma flares in sensitized patients. Seek medical care for worsening asthma symptoms or increased rescue inhaler need.
Fatigue
mildMild systemic fatigue accompanies moderate spring pollinosis from multi-species urban tree pollen exposure in the late-February through April window.
When to see a doctor
Hackberry pollen allergy symptoms, where present, are those of seasonal allergic rhinoconjunctivitis during late February through April: nasal congestion, sneezing, watery rhinorrhea, itchy eyes, and pharyngeal pruritus. Because hackberry has no characterized allergens and limited clinical data, the proportion of spring pollinosis patients with specific hackberry sensitization is unknown. Many patients with February-to-April urban tree pollen symptoms are multiply sensitized to elm, maple, birch, and other co-occurring tree pollens — hackberry may be contributing to this multi-allergen spring burden without being independently identified. Patients with asthma should be aware that early spring tree pollen from multiple sources including hackberry can trigger bronchospasm; increasing rescue inhaler use during late February through March in urban settings may reflect the beginning of the spring tree pollen season rather than any non-allergic cause. Given the evidence gaps, a board-certified allergist should evaluate the complete spring tree pollen picture rather than focusing on hackberry in isolation. If you have confirmed hemp (Cannabis) or hop pollen sensitization, discuss the theoretical Cannabaceae cross-reactivity with your allergist — though no evidence currently confirms this hypothesis.
Hackberry Pollen and Asthma
Direct data linking hackberry specifically to asthma exacerbation is limited due to the absence of characterized allergens and the challenge of distinguishing hackberry from co-occurring tree pollen contributions during the February-to-April urban spring window. However, urban tree pollen as a category — including early pollinators like hackberry, elm, and maple — is a recognized trigger for spring asthma exacerbations. Asthmatic patients in eastern and central US cities who experience worsening symptoms in late February through March should consider the possibility that early spring tree pollen (including hackberry) is contributing, even if their allergy testing panel does not specifically include hackberry extract. A board-certified allergist can evaluate the full spring tree pollen sensitization picture and advise on asthma management through the extended urban spring pollen window.
Complications of Hackberry Pollen Allergy
Given hackberry's mild and evidence-sparse allergen profile, severe complications are not well-documented. The primary clinical complication is the diagnostic gap: hackberry is absent from most standard US allergy panels, meaning it contributes to the spring pollinosis burden of affected patients without being identified. This results in incomplete allergen identification, potential under-treatment, and missed opportunity for targeted immunotherapy. For patients with hemp or hop sensitization who also experience early spring tree pollen symptoms, the Cannabaceae family cross-reactivity hypothesis adds theoretical complexity to their allergen profile that warrants discussion with an allergist even without definitive cross-reactivity data.
Diagnostic gap from panel absence
Hackberry's absence from standard US allergy panels means it contributes to spring pollinosis without identification, leading to incomplete allergen management and missed immunotherapy targeting.
Multi-allergen spring season complexity
Late February through April involves simultaneous release of elm, maple, hackberry, oak, and birch pollens; disentangling individual contributions requires comprehensive tree pollen panel testing including less common species.
Recurrent bacterial sinusitis
Unmanaged spring pollinosis from any cause including unrecognized hackberry sensitization increases recurrent sinusitis risk through sustained nasal mucosal inflammation.
What Causes Hackberry Pollen Allergy?
Hackberry pollen allergy is caused by IgE sensitization to proteins in windborne pollen from Celtis species, which are wind-pollinated trees that release pollen from inconspicuous flowers appearing with the emerging leaves in late February through April. The allergy mechanism is classical Type I IgE-mediated hypersensitivity — pollen proteins deposited on nasal and conjunctival mucosa sensitize atopic individuals, with subsequent exposures triggering mast cell degranulation and histamine release.
Common hackberry (Midwest, Northeast US)
Celtis occidentalis
Sugarberry (Southeast US, river corridors)
Celtis laevigata
European hackberry / Mediterranean hackberry (France, southern Europe)
Celtis australis
How it works
Hackberry pollen allergy is hypothesized to operate through Type I IgE-mediated hypersensitivity based on the biology of wind pollination and the documented SPT positivity in some urban populations. Windborne Celtis pollen grains — small, tricolporate, characteristic Cannabaceae morphology — are deposited on nasal mucosa in sensitized individuals, where pollen proteins are captured by antigen-presenting cells and processed to generate pollen-specific IgE. On subsequent pollen exposure, IgE cross-linking on mast cells triggers histamine release and the typical immediate allergic rhinitis response. Without characterized allergen proteins, the specific molecular triggering mechanism cannot be defined more precisely. Whether cross-reactive IgE from hemp or hop sensitization can recognize hackberry pollen proteins via shared Cannabaceae protein families remains an important open research question.
The key clinical context is the Cannabaceae family membership: hackberry shares its plant family with Cannabis sativa (hemp, marijuana) and Humulus japonicus (Japanese hop) — both of which have characterized allergens and documented aeroallergen significance. Hemp has WHO/IUIS-characterized allergens including Can s 2 (profilin), Can s 3 (nsLTP), Can s 4, and Can s 5 (PR-10).
Japanese hop's major allergen Hum j 6 (pectin methylesterase inhibitor) is also WHO/IUIS-listed. Whether Celtis pollen shares any of these protein families with sufficient sequence identity for IgE cross-reactivity has not been investigated.
Former Ulmaceae classification adds another potential cross-reactivity dimension: elm (Ulmus) pollen allergenicity is well-established clinically, though — remarkably — no Ulmus allergens have been characterized either. Hackberry was the most commonly planted Dutch-elm-disease-resistant street tree replacement in US cities, meaning it inherited elm's urban planting density across the country.
Risk factors to watch for
Urban residence in eastern or central US
Hackberry was widely planted as a street tree and shade tree in eastern and central US cities, creating concentrated urban exposure particularly in early spring.
Atopic background with spring pollinosis
Patients with existing spring tree pollen allergies (elm, birch, oak) who develop February-to-April symptoms before or concurrent with other tree pollen seasons should consider hackberry as a potential contributing trigger.
Hemp or hop pollen sensitization (theoretical)
Patients with confirmed Cannabis or Humulus sensitization may carry IgE antibodies cross-reactive with Celtis Cannabaceae family proteins — this cross-reactivity hypothesis has not been confirmed but warrants awareness.
Living near river corridors or bottomlands
Native Celtis populations are dense in river corridor habitats and bottomland forests throughout the eastern US, creating localized high-exposure zones for adjacent residents during late February through April.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
How Is Hackberry Pollen Allergy Diagnosed?
Diagnosing hackberry pollen allergy requires access to Celtis pollen extract for skin prick testing — which is not part of standard national allergy testing panels. Some regional allergy extract providers offer Celtis species extracts, particularly in eastern and central US markets where hackberry is commonly planted. Positive SPT with Celtis extract in a patient with February-April rhinitis symptoms supports hackberry sensitization. Because no characterized allergens exist, specific IgE blood tests for hackberry-specific proteins are not available through standard commercial laboratories. The practical diagnostic approach for patients with unexplained late-February through April rhinitis in eastern US urban settings is comprehensive spring tree pollen panel testing including elm, maple, birch, oak, alder, and — where extract is available — hackberry and zelkova, which are commonly planted urban replacement trees with similar evidence gaps. For patients who want to evaluate their full environmental allergen profile, at-home allergy testing services such as Curex offer panels covering 40+ common allergens and results typically within 5 days — often with insurance coverage. These panels can identify co-occurring tree pollen sensitizations that are part of the spring pollinosis picture even where hackberry-specific testing is not yet available.
Skin Prick Test — Celtis Extract
SPT with Celtis pollen extract applied via lancet; wheal formation at 15 minutes confirms IgE-mediated sensitization. Available through select regional allergy extract providers.
Comprehensive Spring Tree Pollen Panel
Testing with a broad spring tree pollen panel (elm, maple, birch, oak, alder, ash, walnut) identifies the full spectrum of February-to-May sensitizers in urban patients with spring pollinosis.
Hemp/Cannabis-Specific IgE (If Family Cross-Reactivity Suspected)
For patients with both early spring symptoms and suspected hemp/Cannabis sensitization, specific IgE for Can s 2/3/4/5 provides baseline Cannabaceae family allergen data. Cannot confirm Celtis cross-reactivity currently.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizTreatment Options for Hackberry Pollen Allergy
See how different approaches stack up for managing your allergy symptoms long-term.
Treatment of hackberry pollen allergy follows standard seasonal allergic rhinitis management principles. The February through April window is brief but intense for urban tree pollen exposure, and the multi-species nature of early spring pollen means pharmacotherapy must address the cumulative allergen burden rather than hackberry specifically. For patients with confirmed hackberry sensitization through specific SPT, allergen-specific immunotherapy using Celtis extract can be pursued. For the majority of patients with spring pollinosis from the urban tree pollen complex (elm, maple, birch, oak, hackberry), a comprehensive multi-allergen SLIT or SCIT formulation provides the most practical approach.
Intranasal Corticosteroid Sprays
Daily nasal corticosteroids started before February hackberry pollen onset provide the most effective single-agent control of early spring tree pollen rhinitis.
Fluticasone (Flonase), mometasone (Nasonex), budesonide (Rhinocort), triamcinolone (Nasacort)
30–50% reduction in nasal symptom scores in seasonal rhinitis meta-analyses; most effective when started 1 to 2 weeks before expected season onset
Oral Second-Generation Antihistamines
Daily antihistamines during the early spring tree pollen window control sneezing, rhinorrhea, and eye symptoms.
Cetirizine (Zyrtec), fexofenadine (Allegra), loratadine (Claritin), levocetirizine (Xyzal)
40–60% reduction in histamine-mediated rhinitis symptoms with daily antihistamine use in clinical trials
Allergen Avoidance
During late February through April when hackberry and other early tree pollens are active, behavioral measures include staying indoors on high-pollen mornings, using HEPA filtration, and showering after outdoor activity.
No medication — behavioral measures
Avoidance measures reduce cumulative exposure by an estimated 20–40% when consistently applied; most effective combined with pharmacotherapy
Allergen Immunotherapy — Subcutaneous (Allergy Shots)
Subcutaneous immunotherapy with a spring tree pollen panel (including elm, maple, birch, oak, and Celtis if extract available) provides durable desensitization to the full early spring urban tree pollen complex.
Multi-allergen spring tree pollen extract panel
Spring tree pollen SCIT shows 60–85% sustained symptom reduction in clinical trials over 3 to 5 years
Allergen Immunotherapy — Sublingual (SLIT Drops)
At-home SLIT drops formulated with the spring urban tree pollen panel provide convenient desensitization without weekly clinic visits — practical for managing the multi-month spring tree pollen season.
Multi-allergen sublingual drops (spring tree pollen panel)
SLIT for spring tree pollen shows 60–80% symptom reduction in clinical trials; at-home administration improves adherence across the full 3 to 5-year course
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy for Hackberry and Spring Tree Pollen Allergy
Instead of masking symptoms, immunotherapy retrains your immune system.
For patients with spring pollinosis including hackberry sensitization, allergen immunotherapy targeting the urban spring tree pollen panel is the disease-modifying treatment that addresses the root cause of seasonal symptoms. Because hackberry pollen season overlaps completely with elm, maple, birch, and oak pollen release from late February through April, a multi-allergen immunotherapy formulation covering the full urban spring tree panel provides the most comprehensive benefit. Hackberry-specific Celtis extract may be incorporated where available. Sublingual immunotherapy drops, offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), deliver custom-formulated allergen drops under the tongue at home each day, eliminating the weekly clinic requirement for allergy shots and making adherence across the full 3 to 5-year course more achievable for most patients. In a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy, adherence stayed above 90%, clinically meaningful symptom improvement rose to 45% of patients by two years, and quality-of-life improvement reached 90.7%. The Cannabaceae family cross-reactivity hypothesis between hackberry and hemp is clinically interesting but does not change the immunotherapy approach — tree pollen SLIT and SCIT target the pollen protein sensitization regardless of family classification. Patients with confirmed hemp pollen sensitization who also have early spring symptoms should discuss with their allergist whether a Cannabaceae family allergen consideration should inform their immunotherapy formulation.
Full Spring Tree Panel Testing
Request a comprehensive spring tree pollen SPT panel including elm, maple, birch, oak, and Celtis where extract is available to identify all February-to-April sensitizers.
Start Medications Pre-Season
Begin intranasal corticosteroids in early February — before hackberry's late-February pollen onset — to establish protective coverage before the first spring tree pollen exposure.
Initiate Multi-Allergen SLIT
SLIT drops targeting the full spring urban tree pollen panel provide at-home desensitization for the multi-species spring allergen burden.
Reassess Each Spring Season
Monitor symptom improvement each February through April with successive immunotherapy; progressive tolerance develops across the 3 to 5-year course.
“Multi-allergen spring tree pollen SLIT shows 60–80% symptom reduction in clinical trials; hackberry sensitization addressed as part of the broader spring urban tree panel”
Treat your Hackberry Pollen allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing · Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living With Hackberry Pollen Allergy
Living with hackberry pollen allergy is primarily about adjusting your spring allergy calendar to begin earlier than typical — most patients with spring pollinosis expect their symptoms to begin in April with oak and grass pollen, but hackberry's late February onset means the allergy season actually begins six weeks earlier. Recognizing the early-season February symptoms as part of your spring allergy rather than attributing them to colds, dry winter air, or non-specific irritants is the first practical step. For urban residents in the eastern and central US, hackberry is a ubiquitous street tree that was planted extensively as an elm disease replacement, meaning it is literally on most city blocks in affected regions — targeted avoidance is not realistic, making pharmacotherapy and immunotherapy the appropriate management tools.
The early spring allergy calendar
Spring tree pollen season in eastern US cities starts in late February with hackberry and elm, not in April with oaks. Adjust your medication start date accordingly — proactive pre-season treatment starting in early February provides substantially better protection than reactive treatment started after symptoms appear.
The hemp family connection — context and limits
Hackberry belongs to the same plant family (Cannabaceae) as Cannabis (hemp/marijuana) and Humulus (hop). The cross-reactivity hypothesis is scientifically plausible given shared family proteins, but has not been confirmed in published research. If you are also sensitized to hemp or hop pollen, mention this to your allergist when discussing spring tree pollen management — the connection may eventually prove clinically relevant as more research accumulates.
Identifying hackberry in urban settings
Hackberry trees are common urban street trees recognizable by their distinctive corky, ridged gray-brown bark with irregular warty protrusions. In winter and early spring before leaves emerge, this bark pattern is the identification clue. Learning to recognize hackberry trees helps you anticipate exposure zones in your neighborhood during the late-February through April pollen season.
Hackberry Pollen Season
Hackberry pollen season begins in late February — when most other urban trees are still dormant — making it one of the earliest spring tree pollen sources in eastern and central US cities. The season extends through April and overlaps with the early-season tree pollen surge of elm, maple, and poplar. The very early onset of hackberry pollination means that patients with February rhinitis symptoms in urban areas, attributing them to 'end of winter' non-specific causes, may actually be experiencing early hackberry pollen exposure. The late-February through April window in the eastern US is a period of rapidly escalating multi-species tree pollen: hackberry begins in late February, overlapping with elm and maple in March, then oak and birch in April. Attributing February-March symptoms specifically to hackberry is diagnostically challenging without specific testing because the pollen season overlaps with multiple co-occurring tree pollen sources. In the Southeast US, C. laevigata may begin pollinating as early as late January in warm winters, extending the potential exposure window further.
Late February
low intensity
March - April
medium intensity
How to Prevent Hackberry Pollen Allergy Symptoms
Preventing hackberry pollen allergy symptoms requires attention to the early February onset of the spring tree pollen season — earlier than most patients expect their allergies to begin. Proactive measures started in late January or early February, before the first late-February hackberry pollen release, provide the best protection for the multi-species urban spring tree pollen window that follows.
Start pre-season medications in early February
Begin intranasal corticosteroids 1 to 2 weeks before expected hackberry season onset in late February — this is earlier than most patients start spring allergy medications, providing important early-season protection.
Monitor late-winter pollen counts
Check AAAAI National Allergy Bureau data for your city in late February and March — tree pollen counts rising early in the season signal hackberry and elm pollination beginning.
Use HEPA air filtration
HEPA purifiers in bedroom and main living areas reduce indoor airborne early spring tree pollen load, particularly important in neighborhoods with dense hackberry street tree plantings.
Shower and change after outdoor time
Early spring outdoor activities in urban areas expose hair and clothing to tree pollen from multiple species including hackberry; showering after returning home reduces nighttime exposure.
Identify hackberry trees in your neighborhood
Hackberry trees are easily identified in winter by their distinctive corky, warty gray bark. Knowing where the trees are in your immediate neighborhood helps anticipate high-exposure zones during late February through April.
Prognosis for Hackberry Pollen Allergy
The prognosis for hackberry pollen allergy is generally favorable because, as a mild spring seasonal allergen with a defined February-to-April window, symptoms can be managed effectively with standard pharmacotherapy. The evidence gap — no characterized allergens, limited sensitization data — means that many patients are managed empirically as part of the urban spring tree pollen complex rather than receiving hackberry-specific targeting; outcomes appear to be clinically acceptable within this broader approach. Patients who are specifically tested for and confirmed to have hackberry sensitization, and who pursue multi-allergen spring tree pollen immunotherapy including Celtis extract, can expect 60 to 85 percent long-term symptom reduction consistent with tree pollen allergen immunotherapy outcomes more broadly. The long-term prognosis is best for patients who take the proactive approach: early medication start, comprehensive allergen testing, and immunotherapy initiation before progressive sensitization escalates mild rhinitis toward more severe disease.
Key takeaways
Hackberry (Celtis, Cannabaceae) is an early spring urban tree aeroallergen with pollen release beginning in late February — earlier than most spring allergens
No characterized allergens exist for Celtis — the Cannabaceae family membership (hemp, hop) creates a cross-reactivity hypothesis that has not yet been confirmed
Multi-allergen spring tree pollen immunotherapy (SLIT or SCIT) is the disease-modifying treatment for significant spring pollinosis including the hackberry component
Hackberry is absent from most standard US allergy panels — specific testing requires requesting Celtis extract by name from an allergist with access to regional species extracts
Hackberry is a botanically interesting early-spring allergen because it sits in the Cannabaceae family alongside hemp and hops — the hemp-hackberry cross-reactivity hypothesis is biologically plausible but clinically unconfirmed, and patients with spring symptoms near hackberry trees should be tested for the better-characterized early pollens like elm and maple first.
Frequently Asked Questions
Hackberry (Celtis occidentalis and C. laevigata) is a deciduous shade tree widespread in eastern and central US urban landscapes. It was planted extensively as a street tree after Dutch elm disease devastated American elm populations — inheriting elm's urban abundance and distribution. Hackberry is wind-pollinated: it produces small, inconspicuous flowers that release pollen into the air in late February through April without relying on insects for pollination. Windborne pollen from any tree species can sensitize atopic individuals and trigger IgE-mediated rhinoconjunctivitis on subsequent exposures. Despite this well-understood mechanism, hackberry's specific allergen proteins have never been characterized by the WHO/IUIS, meaning molecular testing is not available and the exact proteins responsible for sensitization are unknown.
Medical References
- [1]Ickovic MR, Thibaudon M, Sutra JP, Calleja M. Celtis australis: a new allergenic pollen in France. Clin Exp Allergy. 1993;23(9):777–782.
- [2]Jahn-Schmid B, Hauser M, Wopfner N, et al. Humulus japonicus pollen allergy: clinical and molecular characterisation. Clin Exp Allergy. 2012;42(6):920–929.
- [3]D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy. 2007;62(9):976–990.
- [4]Rodríguez R, Villalba M, Batanero E, et al. Emerging pollen allergens. Biomed Pharmacother. 2007;61(2–3):86–96.
- [5]AAAAI. "Pollen Count" (National Allergy Bureau).
- [6]Cariñanos P, Casares-Porcel M. Urban green zones and related pollen allergy: a review. Allergy. 2011;66(9):1097–1107.
- [7]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [8]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Hackberry Pollen allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.
